Phase 2 Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children who have been diagnosed with autism spectrum disorder and also have difficulties with self-regulation (such as managing emotions, behaviour, or responses)
- Children who are able to take part in a treatment called rTMS (repetitive transcranial magnetic stimulation), which uses gentle magnetic pulses near the head (confirm with trial site)
Who may not be able to join:
- Children who have been diagnosed with autism spectrum disorder but do not have any self-regulation difficulties alongside it
- Children for whom TMS treatment would not be safe, including those with a personal or family history of seizures, or who have metal implants in their body
- Children who have other neurological conditions such as epilepsy or a history of stroke
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Deryk Beal, PhD, Holland Bloorview Research Institute
Phone: 416-425-6220
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recruitment; Attrition; Adherence; Blinding success
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.